Add to Favourites
To login click here
Seismic Therapeutic, Inc. will be presenting data on their novel therapeutics for autoimmune diseases and their IMPACT platform that utilizes machine learning for drug discovery at three upcoming scientific conferences. Their two lead drug candidates, S-1117 and S-4321, will be highlighted.